Immune Therapy Holdings (Sweden)
Immune Therapy Holdings AB or ITH is a Swedish biotechnology R&D holding company headquartered at the Karolinska Institutet and Karolinska University Hospital in Stockholm. ITH's research is primarily focused on its Tailored Leukapheresis treatment for immune mediated inflammatory diseases. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Immune Therapy Holdings (Sweden), Sweden, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
74%
Total
Publications
133
Total Open
Publications
98
Total
Citations
3.7K
Open Access
Percentage
74%
Total
Publications
133
Total Open
Publications
98
Total
Citations
3.7K
Breakdown
Publisher Open
22%
Both
45%
Other Platform Open
6%
Closed
27%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 41%
36
Hybrid 35%
31
No Guarantees 24%
21
Other Platform Open
Domain 79%
53
Institution 52%
35
Other Internet 24%
16
Preprint 4%
3
Public 3%
2
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 53 |
doaj.org OAI-PMH Repository | Institution | 22 |
Unknown Repository | Other Internet | 14 |
Uppsala University | Institution | 5 |
Royal Netherlands Academy of Arts and Sciences | Institution | 4 |
helsinki.fi OAI-PMH Repository | Institution | 3 |
bioRxiv | Preprint | 3 |
University of Szeged | Institution | 2 |
University of Manchester | Institution | 2 |
University of Geneva | Institution | 2 |